AnaptysBio: 'Hold' As Spin-Off Shifts Pipeline To First Tracks Biotherapeutics (ANAB)
Summary
AnaptysBio spins off TRAX, shifting to royalties. Here's what investors need to know about the move.
Description
AnaptysBio spins off TRAX, shifting to royalties. Here's what investors need to know about the move.
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source